Cephalosporins in overcoming β-lactamase-producing bacteria and preservation of the interfering bacteria in the treatment of otitis, sinusitis and tonsillitis

References

• Brook I. The role of β-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev. Inf. Dis.6, 601–607 (1984).
   PubMedGoogle Scholar
• Doern GV. Resistance among problem respiratory pathogens in pediatrics. Pediatr. Infect. Dis. J.14, 420–423 (1995).
   PubMed Web of Science ®Google Scholar
• Richter SS, Brueggemann AB, Huynh HK et al. A 1997–1998 National Surveillance Study, Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US institutions. Int. J. Antimicrob. Agents13, 99–107 (1999).
   PubMed Web of Science ®Google Scholar
• Brook I, Calhoun L, Yocum P. β-lactamase-producing isolates of Bacteroides species from children. Antimicrob. Agents Chemother.18, 264–266 (1980).
   PubMed Web of Science ®Google Scholar
• Brook I, Pazzaglia G, Coolbaugh JC, Walker RI. In vivo protection of group A β-hemolytic streptococci by β-lactamase producing Bacteroides species. J. Antimicrob. Chemother.12, 599–606 (1983).
   PubMed Web of Science ®Google Scholar
• Brook I, Pazzaglia G, Coolbaugh JC, Walker RI. In vivo protection of penicillin susceptible Bacteroides melaninogenicus from penicillin by facultative bacteria which produce β-lactamase. Can. J. Microbiol.30, 98–104 (1984).
   PubMed Web of Science ®Google Scholar
• Simon HM, Sakai W. Staphylococcal anatagosim to penicillin group therapy of hemolytic streptococcal pharyngeal infection, effect of oxacillin. Pediatrics31, 463–469 (1963).
   PubMed Web of Science ®Google Scholar
• Scheifele DW, Fussell SJ. Frequency of ampicillin resistant Haemophilus parainfluenzae in children. J. Infect. Dis.143, 495–498 (1981).
   PubMed Web of Science ®Google Scholar
• Brook I, Yocum P. In vitro protection of group A β-hemolytic streptococci from penicillin and cephalothin by Bacteroides fragilis.Chemotherapy29, 18–23 (1983).
   PubMed Web of Science ®Google Scholar
• Brook I. Presence of β-lactamase-producing bacteria and β-lactamase activity in abscesses. Am. J. Clin. Pathol.86, 97–101 (1986).
   PubMed Web of Science ®Google Scholar
• Brook I. Quantitative cultures and β-lactamase activity in chronic suppurative otitis media. Ann. Otol. Rhinol. Laryngol.98, 293–297 (1989).
   PubMed Web of Science ®Google Scholar
• Brook I, Yocum P. Bacteriology and β-lactamase activity in ear aspirates of acute otitis media that failed amoxicillin therapy. Pediatr. Infect. Dis. J.14, 805–808 (1995).
   PubMed Web of Science ®Google Scholar
• O’Keefe, JP, Tally FP, Barza M, Gorbach SL. Inactivation of penicillin-G during experimental infection with Bacteroides fragilis.J. Infect. Dis.137, 437–442 (1978).
   PubMed Web of Science ®Google Scholar
• Brook I, Yocum P, Frazier EH. Bacteriology and β-lactamase activity in acute and chronic maxillary sinusitis. Arch. Otolaryngol. Head Neck Surg.122, 418–422 (1996).
   PubMedGoogle Scholar
• Brook I, Yocum P, Friedman EM. Aerobic and anaerobic flora recovered from tonsils of children with recurrent tonsillitis. Ann. Otol. Rhinol. Laryngol.90, 261–263 (1981).
   PubMed Web of Science ®Google Scholar
• Brook I, Yocum P. Quantitative measurement of β-lactamase levels in tonsils of children with recurrent tonsillitis. Acta Otolaryngol Scand.98, 456–459 (1984).
   Google Scholar
• Brook I, Gober AE. Monthly changes in the rate of recovery of penicillin-resistant organisms from children. Pediatr. Infect. Dis. J.16, 255–257 (1997).
   PubMed Web of Science ®Google Scholar
• Brook I. β-lactamase-producing bacteria recovered after clinical failures with various penicillin therapy. Arch. Otolaryngol.110, 228–231 (1984).
   PubMedGoogle Scholar
• Brook I, Gober AE. Emergence of β-lactamase-producing aerobic and anaerobic bacteria in the oropharynx of children following penicillin chemotherapy. Clin. Pediatr.23, 338–341 (1984).
   PubMed Web of Science ®Google Scholar
• Brook I. Emergence and persistence of β-lactamase-producing bacteria in the oropharynx following penicillin treatment. Arch. Otolaryngol. Head Neck Surg.114, 667–670 (1988).
   PubMedGoogle Scholar
• Tuner K, Nord CE. Emergence of β-lactamase producing microorganisms in the tonsils during penicillin treatment. Eur. J. Clin. Microb.5, 399–404 (1986).
   PubMedGoogle Scholar
• Brook I, Gober AE. Prophylaxis with amoxicillin or sulfisoxazole for otitis media, effect on the recovery of penicillin-resistant bacteria from children. Clin. Infect. Dis.22, 143–145 (1996).
   PubMed Web of Science ®Google Scholar
• Pichichero ME, Casey JR. The evidence base for cephalosporin superiority over penicillin in streptococcal pharyngitis. Diagn. Microbiol. Infect. Dis.57(3 Suppl.), S39–S45 (2007).
   PubMed Web of Science ®Google Scholar
• Knudsin RB, Miller JM. Significance of the Staphylococcus aureus carrier state in the treatment of disease due to group A streptococci. N. Engl. J. Med.271, 1395–1397 (1964).
   PubMed Web of Science ®Google Scholar
• Kovatch AL, Wald ER, Michaels RH. β-lactamase-producing Branhamella catarrhalis causing otitis media in children. J. Pediatr.102, 260–263 (1983).
   Web of Science ®Google Scholar
• Brook I, Yocum P. Bacteriology of chronic tonsillitis in young adults. Arch. Otolaryngol.110, 803–805 (1984).
   PubMedGoogle Scholar
• Reilly S, Timmis P, Beeden AG, Willis AT. Possible role of the anaerobe in tonsillitis. J. Clin. Path.34, 542–547 (1981).
   PubMed Web of Science ®Google Scholar
• Chagollan JR, Macias JR, Gil JS. Flora indigena de las amigalas. Invest. Med. Int.11, 36–43 (1984).
   Google Scholar
• Tuner K, Nord CE. β lactamase-producing microorganisms in recurrent tonsillitis. Scand. J. Infect. Dis.(Suppl.) 39, 83–85 (1983).
   Google Scholar
• Brook I. Role of β-lactamase-producing bacteria in penicillin failure to eradicate group A streptococci. Pediatr. Infect. Dis.4, 491–495 (1985).
   PubMedGoogle Scholar
• Roos K, Grahn E, Holn SE. Evaluation of β-lactamase activity and microbial interference in treatment failures of acute streptococcal tonsillitis. Scand. J. Infect. Dis.18, 313–318 (1986).
   PubMed Web of Science ®Google Scholar
• Brook I, Gober AE. Resistance to antimicrobials used for the therapy of otitis and sinusitis, effect of previous antimicrobial therapy and smoking. Ann. Otol. Rhinol. Laryngol.108, 645–647 (1999).
   PubMed Web of Science ®Google Scholar
• Heimdahl A, Von Konow L, Nord CE. Isolations of β-lactamase-producing Bacteroides strains associated with clinical failures with penicillin treatment of human orofacial infections. Arch. Oral Biol.25, 288–292 (1980).
   Web of Science ®Google Scholar
• Brook I, Hirokawa R. Treatment of patients with recurrent tonsillitis due to group A β-hemolytic streptococci. A prospective randomized study comparing penicillin, erythromycin and clindamycin. Clin. Pediatr.24, 331–336 (1985).
   PubMed Web of Science ®Google Scholar
• Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A strepharyngo-tonsillitisococcal tonsillopharyngitis in adults. Clin. Infect. Dis.38, 1526–1534 (2004).
   PubMed Web of Science ®Google Scholar
• Pichichero ME. Cephalosporins are superior to penicillin for treatment of strepharyngo-tonsillitisococcal tonsillopharyngitis, is the difference worth it? Pediatr. Infect. Dis. J.12, 268–274 (1993).
   PubMed Web of Science ®Google Scholar
• Brook I. Treatment of patients with acute recurrent tonsillitis due to group A β-haemolytic streptococci, a prospective randomized study comparing penicillin and amoxicillin/clavulanate potassium. J. Antimicrob. Chemother.24, 227–233 (1989).
   PubMed Web of Science ®Google Scholar
• Kaplan EL, Johnson DR. Eradication of group A streptococci from the upper respiratory tract by amoxicillin with clavulanate after oral penicillin V treatment failure. J. Pediatr.113, 400–403 (1988).
   PubMed Web of Science ®Google Scholar
• Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics.113, 866–882 (2004).
   PubMed Web of Science ®Google Scholar
• Casey JR, Pichichero ME. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Clin. Infect. Dis.38, 1526–1534 (2004).
   PubMed Web of Science ®Google Scholar
• Brook I. Microbiology and principles of antimicrobial therapy for head and neck infections. Infect. Dis. Clin. North Am.21, 355–391 (2007).
   PubMed Web of Science ®Google Scholar
• Edwards CA, Parrett AM. Intestinal flora during the first months of life, new perspectives. Br. J. Nutr.88(Suppl. 1), S11–S18 (2002).
   PubMed Web of Science ®Google Scholar
• Bibel DJ, Aly R, Bayles C, Strauss WG, Shinefield HR, Maibach HI. Competetive adherence as a mechanism of bacterial interference. Can. J. Microbiol.29, 700–703 (1983).
   PubMed Web of Science ®Google Scholar
• Smith H. The revival of interest in mechanisms of bacterial pathogenicity. Biol. Rev.70, 277–316 (1995).
   PubMed Web of Science ®Google Scholar
• Drider D, Fimland G, Hechard Y, McMullen LM, Prevost H. The continuing story of class IIa bacteriocins. Microbiol. Mol. Biol. Rev.70, 564–582 (2006).
   PubMed Web of Science ®Google Scholar
• Uehara Y, Agematsu K, Kikuchi K et al. Secretory IgA, salivary peroxidase, and catalase-mediated microbicidal activity during hydrogen peroxide catabolism in viridans streptococci, pathogen coaggregation. J. Infect. Dis.194, 98–107 (2006).
   PubMed Web of Science ®Google Scholar
• Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol. Head Neck Surg.133, 139–146 (2005).
   PubMed Web of Science ®Google Scholar
• Roos K, Grahm E, Lind L, Holm S. Treatment of recurrent streptococcal tonsillitis by recolonization with α-streptococci. Eur. J. Clin. Microbiol. Infect. Dis.8, 318–319 (1989).
   PubMed Web of Science ®Google Scholar
• Crow CC, Sandera WE Jr, Longley S. Bacterial interference. II. Role of the normal throat flora in prevention of colonization by group A Streptococcus. J. Infect. Dis.128, 527–532 (1973).
   PubMed Web of Science ®Google Scholar
• Sanders CC, Sanders WE Jr, Harrowe DJ. Bacterial interference, effects of oral antibiotics on the normal throat flora and its ability to interfere with group A streptococci. Infect. Immun.13, 808–812 (1976).
   PubMed Web of Science ®Google Scholar
• Sanders CC, Nelson GE, Sanders WE. Bacterial interference, IV, epidemiologic determinants of the antagonistic activity of the normal throat flora against group A streptococci. Infect. Immun.16, 599–603 (1977).
   PubMed Web of Science ®Google Scholar
• Beck A. Interference by an α-hemolytic streptococcus of β-hemolytic pathogenic streptococci. Inflammation3, 463–465 (1979).
   PubMed Web of Science ®Google Scholar
• Roos K, Grahn E, Holm SE. Evaluation of β-lactamase activity and microbial interference in treatment failures of acute streptococal tonsillitis. Scand. J. Infect. Dis.18, 313–319 (1986).
   PubMed Web of Science ®Google Scholar
• Fujimori I, Kikushima K, Hisamatsu K, Nozawa I, Goto R, Murakami Y. Interaction between oral α-streptococci and group A streptococci in patients with tonsillitis. Ann. Otol. Rhinol. Laryngol.106, 571–574 (1997).
   PubMed Web of Science ®Google Scholar
• Grahn E, Holm SE. Bacterial interference in the throat flora during a streptococcal tonsillitis outbreak in an apartment house area. Zentralblatt. Bakteriol. Parasitenkd. Infekt. Hyg.256, 72–79 (1983).
   Google Scholar
• Brook I, Gober AE. Role of bacterial interference and β-lactamase-producing bacteria in the failure of penicillin to eradicate group A streptococcal pharyngotonsillitis. Arch. Otolaryngol. Head Neck Surg.121, 1405–1409 (1995).
   PubMedGoogle Scholar
• Brook I, Gober AE. Bacterial interference by aerobic and anaerobic bacteria in children with recurrent group A β-hemolytic streptococcal tonsillitis. Arch. Otolaryngol. Head Neck Surg.125, 552–554 (1999).
   PubMedGoogle Scholar
• Grahn E, Holm SE, Roos K. Penicillin tolerance in β-streptococci isolated from patients with tonsillitis. Scand. J. Infect. Dis.19, 421–426 (1987).
   PubMed Web of Science ®Google Scholar
• Brook I, Gillmore JD. Evaluation of bacterial interference and β-lactamase production in the management of experimental infection with group A β-hemolytic streptococci. Antimicrob. Agents. Chemotherapy37, 1452–1455 (1993).
   PubMed Web of Science ®Google Scholar
• Brook I, Foote PA. Effect of penicillin or cefprozil therapy on tonsillar flora. J. Antimicrob. Chemother.40, 725–728 (1997).
   PubMed Web of Science ®Google Scholar
• Brook I, Foote PA. Efficacy of penicillin versus cefdinir in eradication of group A streptococci and tonsillar flora. Antimicrob. Agents Chemother.49, 4787–4788 (2005).
   PubMed Web of Science ®Google Scholar
• Brook I, Shah K, Jackson W. Microbiology of healthy and diseased adenoids. Laryngoscope110, 994–999 (2000).
   PubMed Web of Science ®Google Scholar
• Faden H, Zaz MJ, Bernstein JM, Brodsky L, Stamievich J, Ogru PL. Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann. Otolo. Rhinolo. Laryngolo.100, 612–615 (1991).
   PubMed Web of Science ®Google Scholar
• Bernstein JM, Sagahtaheri-Altaie S, Dryjd DM, Wactawski-Wende J. Bacterial interference in nasopharyngeal bacterial flora of otitis-prone and non-otitis-prone children. Acta Otorhinolaryngol. Belg.48, 1–9 (1994).
   PubMedGoogle Scholar
• Tano K, Hakansson EG, Holm SE, Hellstrom S. Bacterial interference between pathogens in otitis media and α-haemolytic streptococci analysed in an in vitro model. Acta Otolaryngol.122, 78–85 (2002).
   PubMed Web of Science ®Google Scholar
• Brook I, Yocum P. Bacterial interference in the adenoids of otitis media prone children. Pediatr. Infect. Dis. J.18, 835–837 (1999).
   PubMed Web of Science ®Google Scholar
• Brook I, Gober A. Bacterial interference in the nasopharynx of otitis media prone and not otitis media prone children. Arch. Otolaryngol. Head Neck Surg.126, 1011–1013 (2000).
   PubMedGoogle Scholar
• Brook I, Gober AE. Long-term effects on the nasopharyngeal flora of children following antimicrobial therapy of acute otitis media with cefdinir or amoxycillin–clavulanate. J. Med. Microbiol.54, 553–556 (2005).
   PubMed Web of Science ®Google Scholar
• Tano K, Grahn Hakansson E, Holm SE, Hellstrom S. A nasal spray with α-haemolytic streptococci as long term prophylaxis against recurrent otitis media. Int. J. Pediatr. Otorhinolaryngol.11(62), 17–23 (2002).
   Google Scholar
• Brook I, Foote PA. Effect of antimicrobial therapy with amoxicillin and cefprozil on bacterial interference and β-lactamase production in the adenoids. Ann. Otol. Rhinol. Laryngol.113, 902–905 (2004).
   PubMed Web of Science ®Google Scholar
• Brook I, Gober AE. Bacterial interference in the nasopharynx following antimicrobial therapy of acute otitis media. J. Antimicrob. Chemother.41, 489–492 (1998).
   PubMed Web of Science ®Google Scholar
• Brook I. The role of anaerobic bacteria in sinusitis. Anaerobe12, 5–12 (2006).
   PubMed Web of Science ®Google Scholar
• Jousimies-Somer HR, Savolainen S, Ylikoski JS. Comparison of the nasal bacterial floras in two groups of healthy subjects and in patients with acute maxillary sinusitis. Clin. Micrbiol.27, 2736–2743 (1989).
   PubMed Web of Science ®Google Scholar
• Gwaltney JM Jr, Sydnor A Jr, Sande MA. Etiology and antimicrobial treatment of acute sinusitis. Ann. Otol. Rhinol. Laryngol. Suppl.90(3 Pt 3), 68–71 (1981).
   PubMedGoogle Scholar
• Nylen O, Jeppsson PH, Branefors-Helander P. Acute sinusitis. A clinical bacteriological and serological study with special reference to Haemophilus influenzae.Scand J. Infect. Dis.4, 43–48 (1972).
   PubMedGoogle Scholar
• Brook I, Gober A. Bacterial interference in the nasopharynx and nasal cavity of sinusitis prone and not sinusitis prone children. Acta Otolaryngol.119, 832–836 (1999).
   PubMed Web of Science ®Google Scholar
• Stenfors L E, Raisanen S. The flora of the nasopharynx, with special reference to middle ear pathogens. Acta Otolaryngol. (Stockholm)108, 122–125 (1989).
   PubMed Web of Science ®Google Scholar
• Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A strepharyngo–tonsillitisococci in schoolchildren in Pittsburgh. N. Engl. J. Med.346, 1200–1206 (2002).
   PubMed Web of Science ®Google Scholar
• Tanz R, Shulman T, Sroka A, Marubio S, Brook I, Yogev R. Lack of influence of β-lactamase-production flora on recovery of group A strepharyngo–tonsillitisococci after treatment of acute pharyngitis. J. Pediatrics117, 859–863 (1990).
   PubMed Web of Science ®Google Scholar
• Tanz RR, Shulman ST. Strepharyngo– tonsillitisococcal pharyngitis, the carrier state, definition, and management. Pediatr. Ann.27, 281–285 (1998).
   PubMed Web of Science ®Google Scholar